A Study on the Correlation Between Cardiac-Cerebral Oxygenation Reserve and Cognitive Function Changes in Heart Failure Patients
Assessing the Cardio-Cerebral Oxygenation Reserve in Heart Failure Patients Using Oxygen-Sensitive Magnetic Resonance Imaging Technology
1 other identifier
observational
60
1 country
1
Brief Summary
At different stages of heart failure (HF), the cardiac and cerebral oxygen reserve exhibits varying degrees of decline due to chronic hypoxia and microvascular dysfunction caused by reduced cardiac output, leading to cognitive dysfunction. As a direct marker of microvascular function, early identification and intervention of cardiac and cerebral oxygen reserve are crucial to prevent irreversible damage to organs such as the heart and brain. However, there is currently no precise and effective method to quantify cardiac and cerebral oxygen reserve. Oxygen-sensitive magnetic resonance imaging (OS-MRI), as an emerging functional imaging technique, can dynamically monitor oxygenation changes and oxygen reserve capacity in Homo sapiens tissues. However, due to its technical complexity, its application in combined cardiac and cerebral assessment in HF patients remains underexplored. This prospective, single-center cohort study employs OS-MRI combined with respiratory maneuvers to examine the heart and brain in HF patients at different stages. Continuous image acquisition is performed during hyperventilation to breath-holding, and myocardial oxygen reserve (MORE) and cerebral oxygen reserve (CORE) are derived using MATLAB and CVI42 post-processing software. Cognitive function is assessed using the Montreal Cognitive Assessment (MoCA) scale, with scores \<26 indicating mild cognitive dysfunction. Subsequently, SPSS is used to analyze the correlation between cardiac/cerebral oxygen reserve and MoCA scores, providing imaging-based evidence for early clinical detection of oxygen reserve decline in HF patients and confirming the potential link between cardiac/cerebral oxygen reserve, HF, and cognitive dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2026
CompletedFirst Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 15, 2026
March 20, 2026
March 1, 2026
7 months
March 16, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive function decline
The MoCA scoreless than 26 points is considered to indicate cognitive dysfunction
Within after MRI scanning 24 hours
Study Arms (2)
Heart Failure Patients group
enrolled NYHA II-IV level heart failure patients
Healthy Control group
confirmed to have no ischemic heart disease by physical examination and echocardiography, will be recruited.
Interventions
Before MRI scanning, participant will trained to exhale and hold their breath
Eligibility Criteria
NYHA classification II=IV heart failure patients and age- and sex-matched control group
You may qualify if:
- Aged \>18 years and \<70 years. (2)Hospitalized for HF or clinically diagnosed with HF and admitted as an inpatient
You may not qualify if:
- (1)Concurrent severe non-cardiac oxygen metabolism diseases (e.g., severe Chronic Obstructive Pulmonary Disease (COPD) or end-stage renal failure). (2)Myocardial infarction or stroke within the last 90 days. (3)Contraindications to MRI. (4)Inability to cooperate with the examinations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yan'an Hospital Affiliated to Kunming Medical University
Kunming, Yunnan, 650051, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Student
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
October 15, 2026
Last Updated
March 20, 2026
Record last verified: 2026-03